Anixa Biosciences, Inc. (ANIX) Earnings History
Net Loss37 years of earnings data (1989–2025) · Currently unprofitable on a TTM basis
Loading earnings history...
Anixa Biosciences, Inc. (ANIX) Earnings Overview
As of June 28, 2026, Anixa Biosciences, Inc. (ANIX) reported trailing twelve-month net income of -$10M, reflecting +12.8% year-over-year growth. The company earned $-0.30 per diluted share over the past four quarters.
Looking at the long-term picture, ANIX's historical earnings data spans multiple years. The company achieved its highest annual net income of -$1M in fiscal 1989.
Anixa Biosciences, Inc. is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including IMVT (-$506M net income), NKTR (-$158M net income, -297.1% margin), HALO ($349M net income, 22.7% margin), ANIX has comparable earnings metrics. Compare ANIX vs IMVT →
ANIX Earnings vs Peers
Earnings metrics vs comparable public companies
ANIX Historical Earnings Data (1989–2025)
37 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | -$11M | +13.0% | -$12M | $-0.34 | - | - |
| 2024 | -$13M | -28.0% | -$14M | $-0.39 | - | - |
| 2023 | -$10M | +27.8% | -$11M | $-0.32 | -4671.9% | -5243.3% |
| 2022 | -$14M | -5.0% | -$14M | $-0.45 | - | - |
| 2021 | -$13M | -27.8% | -$13M | $-0.45 | -2528.6% | -2565.6% |
| 2020 | -$10M | +13.0% | -$10M | $-0.46 | - | - |
| 2019 | -$12M | +16.8% | -$12M | $-0.61 | -4658.8% | -4756.0% |
| 2018 | -$14M | -179.4% | -$14M | $-0.79 | -1258.1% | -1232.0% |
| 2017 | -$5M | +0.1% | -$6M | $-0.41 | -1381.8% | -1676.0% |
| 2016 | -$5M | -263.8% | -$5M | $-0.57 | -1672.1% | -1503.0% |
| 2015 | -$1M | +85.6% | $-944,759 | $-0.14 | -14.9% | -10.2% |
| 2014 | -$10M | +4.7% | -$5M | $-1.00 | -261.9% | -137.5% |
| 2013 | -$10M | -137.0% | -$8M | $-1.17 | -2592.3% | -2036.2% |
| 2012 | -$4M | +42.4% | -$4M | $-0.53 | -452.4% | -439.8% |
| 2011 | -$7M | -42.6% | -$5M | $-1.01 | -735.5% | -501.2% |
| 2010 | -$5M | +68.6% | -$5M | $-0.79 | -708.3% | -718.3% |
| 2009 | -$16M | -183.2% | -$7M | $-2.70 | -1561.8% | -693.3% |
| 2008 | -$6M | -6.7% | -$6M | $-1.02 | -282.2% | -290.3% |
| 2007 | -$5M | +28.2% | -$5M | $-1.20 | -1121.1% | -1128.1% |
| 2006 | -$8M | -70.8% | -$8M | $-1.81 | -1494.3% | -1499.6% |
| 2005 | -$4M | -32.5% | -$4M | $-1.14 | -1012.1% | -1015.4% |
| 2004 | -$3M | -7.9% | -$3M | $-0.92 | -679.7% | -680.5% |
| 2003 | -$3M | +5.2% | -$3M | $-0.94 | -1275.2% | -1277.2% |
| 2002 | -$3M | +8.0% | -$3M | $-1.10 | -63.3% | -63.8% |
| 2001 | -$4M | +28.0% | -$4M | $-1.26 | -211.3% | -213.2% |
| 2000 | -$5M | +41.6% | -$5M | $-1.81 | -337.2% | -345.5% |
| 1999 | -$9M | -19.7% | -$8M | $-3.16 | -8500.0% | -8200.0% |
| 1998 | -$7M | -22.4% | -$7M | $-2.69 | -7100.0% | -7100.0% |
| 1997 | -$6M | -7.4% | -$6M | $-2.29 | -5800.0% | -6300.0% |
| 1996 | -$5M | -80.0% | -$6M | $-2.17 | -5400.0% | -6000.0% |
| 1995 | -$3M | +11.8% | -$3M | $-1.30 | -3000.0% | -3300.0% |
| 1994 | -$3M | -21.4% | -$4M | $-1.59 | -3400.0% | -3600.0% |
| 1993 | -$3M | -55.6% | -$3M | $-1.37 | -2800.0% | -2800.0% |
| 1992 | -$2M | -38.5% | -$2M | $-0.91 | -1800.0% | -1900.0% |
| 1991 | -$1M | -18.2% | -$1M | $-0.68 | -1300.0% | -1400.0% |
| 1990 | -$1M | +0.0% | -$1M | $-0.68 | -1100.0% | -1400.0% |
| 1989 | -$1M | - | -$1M | $-0.68 | -1100.0% | -1200.0% |
Download Data
Export ANIX earnings history in CSV or JSON format
Free sign-in required to download data
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
37+ years return with dividends reinvested.
DCA Calculator
See how regular investing compounds over time.
Peer Comparison
Compare growth, multiples, and margins vs sector.
ANIX — Frequently Asked Questions
Quick answers to the most common questions about buying ANIX stock.
What is ANIX earnings per share (EPS)?
ANIX trailing twelve-month (TTM) diluted EPS is $-0.30, reflecting +12.8% year-over-year growth. The 5-year EPS CAGR is N/A. Complete EPS history from 1989 to 2025 is available in the table on this page.
What is Anixa Biosciences, Inc.'s net income?
Anixa Biosciences, Inc. (ANIX) trailing twelve-month net income is $-10M as of 2025. Earnings grew +12.8% year-over-year.
Is ANIX profitable?
ANIX is not currently profitable on a TTM basis, reporting a net loss of $-10M. Net margin is N/A. Investors should monitor for a return to profitability.
What is ANIX's earnings growth rate?
ANIX compound annual EPS growth rates (CAGR): 1-Year: N/A, 3-Year: N/A, 5-Year: N/A, 10-Year: N/A. These figures measure the annualised rate of diluted EPS growth over each period, based on data from 1989 to 2025.
What are ANIX's profit margins?
Anixa Biosciences, Inc. net profit margin is N/A, operating margin is N/A, and gross margin is N/A. Below-average margins reflect competitive or cost pressures. Return on Equity is -66.6%.
Is ANIX growing earnings?
ANIX is growing earnings steadily. YoY EPS growth of +12.8% is consistent with the 5-year CAGR of N/A. TTM net income is $-10M.
What was ANIX's best earnings year?
Anixa Biosciences, Inc.'s highest annual net income on record is $-1M, achieved in fiscal year 1989. Earnings history on this page spans 1989 to 2025 and includes all annual and quarterly figures.
What were ANIX's earnings last quarter?
ANIX's most recent reported quarter was Q2 2026. Net income was $-3M with diluted EPS of $-0.07. For a full breakdown of all quarters, see the quarterly earnings table on this page.